Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease

被引:3
|
作者
Iorga, Cristian [1 ,2 ]
Iorga, Cristina Raluca [1 ,2 ]
Andreiana, Iuliana [1 ,3 ]
Bengulescu, Iustinian [1 ,2 ]
Constantin, Traian [1 ,4 ]
Strambu, Victor [1 ,2 ]
机构
[1] Carol Davila Univ Med & Pharm, Fac Med, Bucharest, Romania
[2] Dr Carol Davila Clin Nephrol Hosp, Surg Clin, Bucharest, Romania
[3] Dr Carol Davila Clin Nephrol Hosp, Nephrol Clin, Bucharest, Romania
[4] Prof Dr Th Burghele Hosp, Dept Urol, Bucharest, Romania
来源
关键词
secondary hyperparathyroidism; total parathyroidectomy; parathormone; chronic kidney disease; hyperparathyroidism recurrence; MANAGEMENT; AUTOTRANSPLANTATION; MORTALITY; HORMONE; CKD;
D O I
10.3389/fendo.2023.1191914
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionSecondary hyperparathyroidism, as a result of chronic kidney disease could be treated medically or surgically. When pharmacotherapy fails, patients undergo surgery - parathyroidectomy, the curative treatment of secondary hyperparathyroidism (SHPT). There are currently 3 accepted surgical techniques, each with supporters or opponents - total parathyroidectomy, subtotal parathyroidectomy and parathyroidectomy with immediate autotransplantation.MethodsIn this paper we described our experience on a series of 160 consecutive patients diagnosed with secondary hyperparathyroidism who underwent surgery, in 27 cases it was totalization of the intervention (patients with previously performed subtotal parathyroidectomy or with supernumerary glands and SHPT recurrence). We routinely perform total parathyroidectomy, the method that we believe offers the best results.ResultsThe group of patients was studied according to demographic criteria, paraclinical balance, clinical symptomatology, pre- and postoperative iPTH (intact parathormone) values, SHPT recurrence, number of reinterventions. In 31 cases we found gland ectopy and in 15 cases we discovered supernumerary parathyroids. A percentage of 96.24% of patients with total parathyroidectomy did not show recurrence.DiscussionsAfter analyzing the obtained results, our conclusion was that total parathyroidectomy is the intervention of choice for patients suffering from secondary hyperparathyroidism when pharmacotherapy fails in order to prevent recurrence of the disease and to correct the metabolic parameters.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Indication of total parathyroidectomy for an Epstein syndrome patient with end-stage renal disease
    Marinescu, Daniela
    Bica, Elena-Catalina
    Ghilusi, Mirela-Corina
    Bica, Marius
    Patrascu, Ana-Maria
    Patrascu, Stefan
    Pantea, Stelian
    Strambu, Victor Dan Eugen
    Surlin, Valeriu
    Margaritescu, Nicolae-Dragos
    Sapalidis, Konstantinos
    Rotaru, Ionela
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2018, 59 (02): : 573 - 576
  • [42] Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis
    McManus, Catherine
    Oh, Aaron
    Lee, James A.
    Hur, Chin
    Kuo, Jennifer H.
    SURGERY, 2021, 169 (01) : 94 - 101
  • [43] Total Parathyroidectomy Without Autotransplantation for Secondary Hyperparathyroidism
    Shih, Ming-Lang
    Duh, Quan-Yang
    Hsieh, Chung-Bao
    Lin, Shih-Hua
    Wu, Hurng-Sheng
    Chu, Paul-Ling
    Chen, Tien-Yu
    Yu, Jyh-Cherng
    WORLD JOURNAL OF SURGERY, 2009, 33 (02) : 248 - 254
  • [44] Total versus subtotal parathyroidectomy for secondary hyperparathyroidism
    Isaksson, Elfin
    Ivarsson, Kerstin
    Akaberi, Shahriar
    Muth, Andreas
    Prutz, Karl-Goran
    Clyne, Naomi
    Sterner, Gunnar
    Almquist, Martin
    SURGERY, 2019, 165 (01) : 142 - 150
  • [45] Prevalence and correlating factors of secondary hyperparathyroidism in dialyzing end stage renal disease (ESRD) patients.
    Song, HC
    Choi, EJ
    Kim, SH
    Chun, JS
    Park, JH
    Shin, SY
    Kim, YO
    Kim, SY
    Chang, YS
    Bang, BK
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1613 - 1614
  • [46] TOTAL PARATHYROIDECTOMY WITH FOREARM AUTOGRAFT FOR SECONDARY HYPERPARATHYROIDISM IN CHRONIC RENAL-FAILURE
    TAKAGI, H
    TOMINAGA, Y
    TANAKA, Y
    UCHIDA, K
    ORIHARA, A
    YAMADA, N
    KAWAI, M
    HAYASHI, S
    TAIRA, N
    KANO, T
    ANNALS OF SURGERY, 1988, 208 (05) : 639 - 644
  • [47] Effects and Safety of Calcimimetics in End Stage Renal Disease Patients with Secondary Hyperparathyroidism: A Meta-Analysis
    Zhang, Qian
    Li, Ming
    You, Li
    Li, Haiming
    Ni, Li
    Gu, Yong
    Hao, Chuanming
    Chen, Jing
    PLOS ONE, 2012, 7 (10):
  • [48] Altered brain structural and cognitive impairment in end-stage renal disease patients with secondary hyperparathyroidism
    Gong, Xijun
    Zou, Liwei
    Wu, Hanqiu
    Shan, Yanqi
    Liu, Guiling
    Zheng, Suisheng
    Wang, Longsheng
    ACTA RADIOLOGICA, 2020, 61 (06) : 796 - 803
  • [49] Cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients below age 5 years
    Joseph, Catherine
    Shah, Shweta
    Geer, Jessica
    Juarez-Calderon, Marisa
    Srivaths, Poyyapakkam R.
    Swartz, Sarah J.
    CLINICAL NEPHROLOGY, 2019, 92 (06) : 279 - 286
  • [50] End-stage renal failure following parathyroidectomy for advanced primary hyperparathyroidism
    Laroche, M
    Garrette, F
    Rostaing, L
    Cantagrel, A
    Mazieres, B
    REVUE DE MEDECINE INTERNE, 1998, 19 (11): : 787 - 791